More Lumos Diagnostics Holdings Ltd. news
Lumos Diagnostics Holdings Ltd.ASX: LDX

Target Market Determination

Jun 6, 2022 at 5:22 AM EDT · Issued by Lumos Diagnostics Holdings Ltd.

Filed with ASX · Jun 6, 2022 at 5:22 AM EDT · 4 pages · English

On 6ix: 6ix.com/news/target-market-determination-5

Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20↗

Lumos Diagnostics Holdings Ltd. on 6ix

In the deck

  • Lumos Diagnostics Holdings — Investor Presentation (June 2022)32 slidesJun 6, 2022

Earlier from Lumos Diagnostics

  • Operational Update and Accelerated Entitlement OfferJun 6, 2022
  • Operational Review & Management ReorganisationApr 10, 2022
  • FebriDx Update - Brazil Market Authorisation & New StudyFeb 27, 2022
  • FY2022 Half Year UpdateFeb 27, 2022
  • Lumos Diagnostics FY22 First Half Year ResultsFeb 27, 2022

Later from Lumos Diagnostics

  • Successful Completion of Institutional Entitlement OfferJun 7, 2022
  • Lumos secures initial development services contractJun 16, 2022
  • Lumos Diagnostics Appoints Doug Ward as CEOJun 21, 2022
  • Security Class Suspension from Quotation LDXOJun 23, 2022
  • ViraDx Receives Interim Order Authorisation in CanadaJun 26, 2022
All Lumos Diagnostics news releases↗

Follow Lumos Diagnostics into a list and get an email when it puts out news.

Follow Lumos Diagnostics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer